Percutaneous coronary intervention in patients refused from surgery: a different entity?

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Patients with left main or multivessel coronary artery disease (CAD) and reduced left ventricular function face poor prognoses after coronary artery bypass grafting (CABG).
• Surgical ineligibility for revascularization in these high-risk patients often leads to suboptimal outcomes with percutaneous coronary intervention (PCI) alone.

Purpose of the Study:

• To review the conditions leading to surgical ineligibility in high-risk CAD patients.
• To analyze the clinical outcomes of PCI in patients deemed ineligible for surgery.
• To evaluate the evidence supporting the use of mechanical circulatory support, specifically Impella, in this patient population.

Main Methods:

• Review of current literature on surgical ineligibility criteria for complex CAD.
• Analysis of clinical outcomes data from studies involving PCI in high-risk, non-surgical candidates.
• Examination of evidence regarding the efficacy and safety of percutaneous left ventricular assist devices (Impella) in protected PCI strategies.

Main Results:

• Surgical ineligibility is a significant predictor of adverse outcomes in patients with severe CAD and depressed left ventricular function.
• Protected PCI using mechanical circulatory support devices may offer a viable alternative revascularization strategy for patients unsuitable for CABG.
• Impella devices have emerged as a key technology facilitating protected PCI in high-risk individuals.

Conclusions:

• Patients with complex CAD and poor ventricular function who are not surgical candidates represent a vulnerable group.
• Protected PCI with mechanical support, such as Impella, is an evolving strategy to improve revascularization outcomes in this population.
• Further research is warranted to solidify the role of mechanical circulatory support in optimizing care for high-risk cardiac patients.